Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Genitourinary 1

Conditions

Prostatic Neoplasms 54Carcinoma, Non-Small-Cell Lung 33Lung Neoplasms 30Breast Neoplasms 29Glioblastoma 23Multiple Myeloma 21Glioma 20Lymphoma 19Pancreatic Neoplasms 17Lymphoma, Large B-Cell, Diffuse 17Carcinoma, Renal Cell 17Urinary Bladder Neoplasms 16Brain Neoplasms 14Sarcoma 13Squamous Cell Carcinoma of Head and Neck 12Rectal Neoplasms 11Neoplasm Metastasis 11Melanoma 11Lymphoma, Non-Hodgkin 11Thyroid Neoplasms 10Ovarian Neoplasms 10Oropharyngeal Neoplasms 10Neuroblastoma 9Mouth Neoplasms 9Medulloblastoma 9Lymphoma, Follicular 9Ependymoma 9Central Nervous System Neoplasms 9Astrocytoma 9Triple Negative Breast Neoplasms 8

Interventions

High-Intensity Focused Ultrasound Ablation 2methyl N-acetylsibirosaminide 1Sildenafil Citrate 1Prostatectomy 1Phentolamine 1Papaverine 1Magnetic Resonance Spectroscopy 1Flutamide 1Finasteride 1Estradiol 1Biopsy 1Anastrozole 1Alprostadil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Sexual Dysfunction, Physiological × Magnetic Resonance Spectroscopy × Clear all
NCT00561314 2013-08-26

High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Completed
33 enrolled
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡